Pregled bibliografske jedinice broj: 984659
Resource utilisation and cost of cervical cancer and dysplasia in Croatia
Resource utilisation and cost of cervical cancer and dysplasia in Croatia // European journal of gynaecological oncology, XL (2019), 1; 40-47 doi:10.12892/ejgo4210.2019 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 984659 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Resource utilisation and cost of cervical cancer and dysplasia in Croatia
Autori
Ivičević Uhernik, Ana ; Vajagić, Maja ; Jelavić, Melita ; Cesarec, August ; Lučić, Ana ; Jovanović, Marino, Lovrić, Zvjezdana ; Šekerija, Mario
Izvornik
European journal of gynaecological oncology (0392-2936) XL
(2019), 1;
40-47
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Cervical cancer ; Cervical dysplasia ; Resource utilisation ; Cost of illness
Sažetak
Purpose of investigation: To analyse resource utilisation and costs due to cervical cancer and dysplasia in Croatia. Materials and Methods: Patients diagnosed with cervical cancer were identified from the Croatian National Cancer Registry. Resource utilisation and costs of cervical cancer treatment for the period of five years after the date of diagnosis were retrieved from the Croatian Health Insurance Fund Claims Database. Patients diagnosed with cervical dysplasia were identified and their resource utilisation and treatment costs during one year following diagnosis were obtained from the Croatian Health Insurance Fund Claims Database. Results were calculated for different healthcare services and disease stages. Results: There were 346 patients diagnosed with cervical cancer in 2008. Total costs of treatment in the five-year period were 2, 177, 071 Euros, while average cost of treatment per patient was 6, 403 Euros. The largest shares of total costs were costs for hospitalisations (73%), followed by outpatient healthcare (17%), and personal sick leave (7%). There were also 14, 913 patients with cervical dysplasia diagnosed in 2012. Total costs of their treatment during one year after the diagnosis were 1, 609, 073 Euros, with average costs per patient of 108 Euros. Outpatient care (48%), followed by hospitalisations (45%), and prescribed medicines (6%) had the greatest share of total costs. Conclusion: Treatment of cervical cancer and dysplasia in Croatia is associated with significant costs and healthcare resource utilisation.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
Hrvatski zavod za javno zdravstvo,
Ekonomski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)